HomeUNVO • TLV
add
Univo Pharmaceuticals Ltd
Previous close
ILA 93,000.00
Market cap
3.06M ILS
P/E ratio
-
Dividend yield
-
Primary exchange
TLV
Market news
Financials
Income Statement
Revenue
Net income
| (ILS) | 2021info | Y/Y change |
|---|---|---|
Revenue | 42.23M | 25.38% |
Operating expense | 23.56M | 95.63% |
Net income | -6.26M | -3,522.40% |
Net profit margin | -14.83 | -2,846.30% |
Earnings per share | — | — |
EBITDA | 1.42M | 0.85% |
Effective tax rate | 2.23% | — |
Balance Sheet
Total assets
Total liabilities
| (ILS) | 2021info | Y/Y change |
|---|---|---|
Cash and short-term investments | 7.78M | -68.07% |
Total assets | 101.13M | 36.67% |
Total liabilities | 54.80M | 48.99% |
Total equity | 46.33M | — |
Shares outstanding | — | — |
Price to book | — | — |
Return on assets | -0.39% | — |
Return on capital | -0.46% | — |
Cash Flow
Net change in cash
| (ILS) | 2021info | Y/Y change |
|---|---|---|
Net income | -6.26M | -3,522.40% |
Cash from operations | -20.36M | -107.17% |
Cash from investing | -11.26M | 23.83% |
Cash from financing | 17.63M | -25.71% |
Net change in cash | -13.96M | -1,530.96% |
Free cash flow | -27.34M | -11.50% |
About
Founded
1993
Website
Employees
76
